SNSS Financial Facts

General and administrative: 4M
Total revenues: 610K
See Full Income Statement

Property and equipment, net: 8K
Commitments: 0
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 11/7/16 *Est. EPS Growth Rate +20.0% *Last Qtr.
Average EPS % Beat Rate +3.2% Revenue Growth Rate -28.6% *Last Qtr.
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/29/16 Q216 -$0.12-$0.10 -$0.02$610K$1.03M N/A Details
5/5/16 Q116 -$0.12-$0.12 $0.00$600K$1K N/A Details
3/10/16 Q415 -$0.15-$0.14 -$0.01$670K$700K N/A Details
11/5/15 Q315 -$0.09-$0.15 +$0.06$700K$1.09M N/A Details
7/30/15 Q215 -$0.15-$0.13 -$0.02$854K$1.21M N/A Details
5/5/15 Q115 -$0.13-$0.16 +$0.03$854K$980K N/A Details
3/12/15 Q414 -$0.02-$0.19 +$0.17$896K$1.17M N/A Details
11/10/14 Q314 -$0.25-$0.17 -$0.08$854K$1.97M N/A Details